Annual Cash & Cash Equivalents
$36.49 M
-$25.90 M-41.51%
December 31, 2023
Summary
- As of February 21, 2025, XGN annual cash & cash equivalents is $36.49 million, with the most recent change of -$25.90 million (-41.51%) on December 31, 2023.
- During the last 3 years, XGN annual cash & cash equivalents has fallen by -$20.95 million (-36.48%).
- XGN annual cash & cash equivalents is now -63.30% below its all-time high of $99.44 million, reached on December 31, 2021.
Performance
XGN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$22.04 M
-$2.44 M-9.98%
September 30, 2024
Summary
- As of February 21, 2025, XGN quarterly cash and cash equivalents is $22.04 million, with the most recent change of -$2.44 million (-9.98%) on September 30, 2024.
- Over the past year, XGN quarterly cash and cash equivalents has dropped by -$6.41 million (-22.54%).
- XGN quarterly cash and cash equivalents is now -81.33% below its all-time high of $118.05 million, reached on March 31, 2021.
Performance
XGN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XGN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.5% | -22.5% |
| 3 y3 years | -36.5% | -79.4% |
| 5 y5 years | +177.2% | -64.1% |
XGN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.3% | at low | -77.8% | at low |
| 5 y | 5-year | -63.3% | at low | -81.3% | at low |
| alltime | all time | -63.3% | +1354.5% | -81.3% | +778.2% |
Exagen Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.04 M(-10.0%) |
| Jun 2024 | - | $24.48 M(-10.2%) |
| Mar 2024 | - | $27.27 M(-25.3%) |
| Dec 2023 | $36.49 M(-41.5%) | $36.49 M(+28.3%) |
| Sep 2023 | - | $28.45 M(-9.6%) |
| Jun 2023 | - | $31.47 M(-39.7%) |
| Mar 2023 | - | $52.18 M(-16.4%) |
| Dec 2022 | $62.39 M(-37.3%) | $62.39 M(-9.2%) |
| Sep 2022 | - | $68.70 M(-10.1%) |
| Jun 2022 | - | $76.39 M(-14.9%) |
| Mar 2022 | - | $89.75 M(-9.7%) |
| Dec 2021 | $99.44 M(+73.1%) | $99.44 M(-6.9%) |
| Sep 2021 | - | $106.77 M(-5.2%) |
| Jun 2021 | - | $112.58 M(-4.6%) |
| Mar 2021 | - | $118.05 M(+105.5%) |
| Dec 2020 | $57.45 M | $57.45 M(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $61.43 M(-3.6%) |
| Jun 2020 | - | $63.70 M(-7.2%) |
| Mar 2020 | - | $68.65 M(-4.8%) |
| Dec 2019 | $72.08 M(+447.6%) | $72.08 M(-7.4%) |
| Sep 2019 | - | $77.83 M(+379.3%) |
| Jun 2019 | - | $16.24 M(+23.3%) |
| Dec 2018 | $13.16 M(+17.1%) | $13.16 M(+424.7%) |
| Dec 2017 | $11.24 M(+348.0%) | - |
| Dec 2015 | $2.51 M(-45.5%) | $2.51 M(-8.3%) |
| Sep 2015 | - | $2.74 M(-6.2%) |
| Jun 2015 | - | $2.92 M(-16.6%) |
| Mar 2015 | - | $3.50 M(-24.0%) |
| Dec 2014 | $4.61 M(-40.5%) | $4.61 M(-35.4%) |
| Sep 2014 | - | $7.12 M(+16.4%) |
| Jun 2014 | - | $6.12 M(-21.0%) |
| Dec 2013 | $7.74 M(+182.1%) | $7.74 M |
| Dec 2012 | $2.75 M | - |
FAQ
- What is Exagen annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Exagen?
- What is Exagen annual cash & cash equivalents year-on-year change?
- What is Exagen quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Exagen?
- What is Exagen quarterly cash and cash equivalents year-on-year change?
What is Exagen annual cash & cash equivalents?
The current annual cash & cash equivalents of XGN is $36.49 M
What is the all time high annual cash & cash equivalents for Exagen?
Exagen all-time high annual cash & cash equivalents is $99.44 M
What is Exagen annual cash & cash equivalents year-on-year change?
Over the past year, XGN annual cash & cash equivalents has changed by -$25.90 M (-41.51%)
What is Exagen quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of XGN is $22.04 M
What is the all time high quarterly cash and cash equivalents for Exagen?
Exagen all-time high quarterly cash and cash equivalents is $118.05 M
What is Exagen quarterly cash and cash equivalents year-on-year change?
Over the past year, XGN quarterly cash and cash equivalents has changed by -$6.41 M (-22.54%)